MedCity Update – May 2015
View this email in your browser

Welcome

From Simon Kerry, MedCity Advisory Board member, CEO of Karus Therapeutics, and co-founder of Angels4LifeSciences

One of the four main goals of MedCity is to nurture an environment in which life science entrepreneurship can thrive. Fundamental to this goal is access to finance, and it has been my great pleasure to be part of the team delivering this aim. The establishment of Angels in MedCity has been one of the great achievements of MedCity’s first year – devised and delivered by London Business Angels in collaboration with Angels4LifeSciences and MedCity.

Since its launch in October last year, we have held three investor workshops and two presentation events for early-stage life sciences companies, bringing together over 100 people who form the foundation of a new and growing investor community focused on life science investment. Our next presentation event will take place in June, and there is still time for potential investors and emerging companies to participate.

Early stage investment in life science companies is an issue close to my heart, as CEO of a fast-growing biotech and a co-founder of Angels4LifeSciences. Securing investment for early stage life science companies is vital for the UK economy, but it has to be knowledgeable, sustainable and positive investment on the part of the angels themselves. Angels in MedCity has huge potential to tick both boxes.

Better understanding between NHS and entrepreneurs vital, says MedCity

Clearer routes to market for entrepreneurs are vital to improving healthcare through innovation, Eliot Forster said as MedCity launched three new guides for SMEs at April’s WIRED Health event. Addressing the key issues and questions that entrepreneurs raise with MedCity, the guides cover navigating the NHS, finding the right working space and raising finance.
Read more

Download the guides

Read more from Eliot on MedCity’s first year in TechCity News

Working with the NHS – an e-health entrepreneur’s experience

“It always struck me as crazy that I could book a flight using my phone yet when I was at work I used scraps of paper and a pencil” – Matt Prime, surgeon and co-founder of e-health company Open Medical, on working with the NHS to introduce innovation. 
Read more about Matt’s experience

Angels in MedCity – June presentation event

The third presentation event for emerging life sciences companies to pitch to angel investors takes place on Thursday 11 June. Find out more about joining as a company or a potential investor here.
Read more about Angels in MedCity

See more about London Business Angels

Alan Barrell on the future of med tech and life sciences

Open innovation thinking, commitment to collaboration and action to match are the foundations on which the UK can transform healthcare, Alan Barrell, MedCity Advisory Board member and professor at Cambridge’s Centre for Entrepreneurial Learning, told the Policy Forum for London in April.
See his full presentation here

UK life sciences ranked world’s second in subject guide

UK universities are ranked second in the world for high quality life sciences research, according to the latest QS World University Rankings by Subject. The study places 13 UK universities in the top 30 for life sciences and medicine, second only to the USA with 32.
Read more

University consultancy – driving industry and innovation

University consultancy contributes over £400m to the UK economy – Andreas Ballis at Imperial Consultants, Bjorn Christianson at UCL Consultants and Michael Hill-King at King’s College London explain how.  

Read the article

MedCity discounts at BioTrinity 2015

MedCity is sponsoring BioTrinity 2015, taking place 11-13 May in west London. Discounts are available to our academic partners using the code BIOT15MedCity599 – please note that you must register with an ‘ac.uk’ email address. 

Find out more and register here

OneStart announces final 10 companies

Life sciences business plan competition and accelerator OneStart has unveiled the final 10 companies set to pitch to investors at the Finals Gala in May.  

See video presentations by the finalists
Read more about OneStart

Call for feasibility studies – management and use of biofilms

BBSRC and Innovate UK are investing up to £2.5m in feasibility studies to encourage better management and use of biofilms. The deadline for applications is 16 September 2015 and there will be a briefing day for potential applicants on 18 June. 

Find out more

World Stem Cells and Regenerative Medicine Congress – MedCity discount

The World Stem Cells and Regenerative Medicine Congress takes place in London from 20 to 22 May.
MedCity has negotiated a 30% discount for members of its community to attend the Congress; to use the offer please book.

See more about the event

BBSRC FLIP fellowships

Applications are open for the next round of fellowships under BBSRC’s Flexible Interchange Programme, which promotes the movement of people between different organisations, including academia and industry. The closing date for applications is 15 July.

Find out more

NICE Scientific Advice seminar

Want to know how NICE assesses value? Scientific Advice seminar for developers of devices and diagnostics takes place on 20 May in Manchester. 

Find out more

Coming up

London Regenerative Medicine Network meeting, 19 May, LRMN and GE Healthcare
Innovative financing opportunities for active & healthy ageing, 3 June, European Commission 
Biotech Investment, 9 June, Consilium Strategic Communications

Email us to share your event

MedCity was established in April 2014 by the Mayor of London with the capital’s three Academic Health Science Centres – Imperial College Academic Health Centre, King’s Health Partners and UCLPartners.

MedCity
2 Royal College Street
London NW1 0NH
T: 020 7691 3588
E: contact@medcitylondon.com 

The next edition of MedCity Update will be sent in June 2015.

Twitter
Twitter

Website
Website

Copyright © 2015 MedCity. All rights reserved.